A Partnership of the Crohn’s & Colitis Foundation and
the American Gastroenterological Association
the American Gastroenterological Association
Join the Conversation
Menu
The Crohn’s & Colitis Congress will provide Early Career Investigators Awards to up to ten abstract presenters for the 2025 meeting. Award recipients will receive complementary registration for the 2025 meeting.
Applicants for the award must:
Applications must be submitted online. Previous recipients of the award are not eligible to apply.
Award notifications will be emailed in mid-December.
Contact info@crohnscolitiscongress.org with any questions.
Ju-Hyun Ahn, University of North Carolina at Chapel Hill
ZINC RESTRICTION BY INTESTINAL E. COLI – PRODUCED YERSINIABACTIN ACTIVATES HIF-1α IN MACROPHAGES TO PROMOTE CD-ASSOCIATED FIBROSIS.
Nicole Anderson, Purdue University
A NOVEL MOUSE MODEL OF CROHN’S DISEASE DRIVEN BY THE INTERACTION OF CD4 T CELLS AND GUT MICROBIOTA-RESPONSIVE γδ T CELLS
Bin Bao, Boston Children’s Hospital, Harvard Medical School
BACTERIAL SPHINGOLIPIDS EXACERBATE COLITIS BY INHIBITING ILC3-DERIVED IL-22 PRODUCTION
Siyan Cao, Washington University in St. Louis School of Medicine
GROUP 3 INNATE LYMPHOID CELLS RELY ON ER STRESS RESPONSE FOR CYTOKINE PRODUCTION IN IBD
Brad Constant, Children’s Hospital Colorado
INSURER-MANDATED MEDICATION UTILIZATION BARRIERS ARE ASSOCIATED WITH DECREASED INSURANCE SATISFACTION AND ADVERSE CLINICAL OUTCOMES: AN IBD PARTNERS SURVEY
Stefania De Santis, Case Western Reserve University
UPREGULATION OF SERPINE1/PAI-1 INDUCED BY IL-33 CONTRIBUTES TO INTESTINAL FIBROSIS IN A CROHN’S DISEASE-LIKE ILEITIS MODEL
Lawrence Kogan, Yale New Haven Hospital
CHRONOLOGICAL AGE INFLUENCES TREATMENT DECISION IN INFLAMMATORY BOWEL DISEASE: AN IBD QORUS COLLABORATIVE STUDY
Marco Losa, Boston Children’s Hospital, Harvard Medical School
BIOACTIVE INTERLEUKIN-1 DETECTED IN IBD PATIENT INTESTINAL BIOPSIES IS A HALLMARK OF ULCERS AND CORRELATES WITH TRANSCRIPTOMIC ASSESSMENTS, INCLUDING AN ULCER-ASSOCIATED GENE MODULE
Natalia Plott, Riley Hospital for Children at Indiana University Health
IMPROVEMENT IN GROWTH AND NUTRITION STATUS AFTER ANTI-TNF THERAPY INITIATION AMONG PATIENTS WITH PEDIATRIC CROHN’S DISEASE: RESULTS FROM THE COMBINE TRIAL
Piu Saha, University of Toledo College of Medicine and Life Sciences
STERILE NEUTROPHILIA INDUCED VIA CXCR4 ANTAGONISM MITIGATES COLONIC INFLAMMATION BY ENHANCING IMMUNOSUPPRESSIVE REGULATORY T CELLS IN MICE
The Crohn’s & Colitis Congress will award complementary registration to the 2022 meeting to up to ten young investigators and five nurses and advanced practice providers. Applications will be accepted from 9 a.m. EDT on Wednesday, Sept. 8 through 9 p.m. EDT on Wednesday, Oct. 20, 2022.
Applicants are:
Recipients will receive complementary registration to the 2021 meeting.
The deadline for young investigators and nurses to submit an application for complementary registration to the 2022 meeting has passed.
Notifications will be sent to all applicants in early December.
Applicants for the Young Investigators Abstract Award must be:
Applications may be submitted at the abstract submission site. To apply for the award, complete the “Awards” fields when submitting an abstract. Applicants are asked to verify their eligibility and also provide a brief (4000 characters maximum) personal statement.
Applicants are not required to be the submitting author of the abstract; instead, submitting authors may complete the application fields on behalf of the applicant provided that the applicant composes the personal statement.
Applications are due at the abstract submission site by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.
Contact Congress administration with any questions about applying.
Nurses and advanced practice providers may apply for complementary registration to the 2022 Crohn’s & Colitis Congress.
As part of the application, applicants are asked to submit their CV and a brief (500 words or less) personal statement.
Applications must be submitted by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.
Contact Congress administration with any questions about applying.
